Early Administration of Small Molecule Glycoprotein IIb/IIIa Inhibitors Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Insights From Randomized Clinical Trials

被引:0
|
作者
Zhang, Feng [1 ]
Dong, Lili [1 ]
Ge, Junbo [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S999 / S999
页数:1
相关论文
共 50 条
  • [1] Upstream vs Deferred Administration of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction - Insights From Randomized Clinical Trials
    Dong, Lili
    Zhang, Feng
    Shu, Xianhong
    [J]. CIRCULATION JOURNAL, 2010, 74 (08) : 1617 - 1624
  • [2] UPSTREAM VERSUS DEFERRED ADMINISTRATION OF SMALL-MOLECULE GLYCOPROTEIN IIB/IIIA INHIBITORS IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM RANDOMIZED CLINICAL TRIALS
    Dong, Lili
    Zhang, Feng
    Shu, Xianhong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [3] Early Administration of Small-Molecule Glycoprotein IIb/IIIa Inhibitors Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From Randomized Clinical Trials
    Dong, Lili
    Zhang, Feng
    Shu, Xianhong
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (02) : 135 - 144
  • [4] Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
    Tereshchenko, Andrey S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 918 - 927
  • [5] Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction - A meta-analysis
    Montalescot, G
    Borentain, M
    Payot, L
    Collet, JP
    Thomas, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03): : 362 - 366
  • [6] The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction
    Svilaas, T
    van der Horst, ICC
    Zijlstra, F
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (23) : 2479 - 2481
  • [7] Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction
    Dobesh, PP
    Kasiar, JB
    [J]. PHARMACOTHERAPY, 2002, 22 (07): : 864 - 888
  • [8] Thrombus Aspiration in Primary Percutaneous Coronary Intervention Improves Early Myocardial Reperfusion in Patients with ST-Segment Elevation Myocardial Infarction without Upstream Use of Glycoprotein IIb/IIIa Inhibitors
    Kim, Jeong Hoon
    Kim, Byung Ok
    Kim, Kwang-Sil
    Goh, Choong-Won
    Byun, Young-Sup
    Kang, Sun-Hee
    Park, Kyung-Min
    Rhee, Kun-Joo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 4B - 4B
  • [9] A meta-analysis of the effectiveness and safety of glycoprotein IIb/IIIa inhibitors for primary percutaneous coronary intervention in unselected patients with st-segment elevation myocardial infarction
    Kouz, Remi
    Kouz, Simon
    Schampaert, Erick
    Rinfret, Stephane
    Eisenberg, Mark
    lauzon, ClauDe
    Nguyen, Michel
    Harvey, Richard
    Huynh, Than
    [J]. CIRCULATION, 2007, 116 (16) : 710 - 711
  • [10] Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with ST-segment elevation myocardial infarction treated with primary or rescue percutaneous coronary intervention
    Osherov, Azriel B.
    Roguin, Ariel
    Aronson, Doron
    Grenadier, Ehud
    Kerner, Arthur
    Boulus, Monther
    Kapeliovich, Michael
    Hani, Amad
    Hammerman, Haim
    Beyar, Rafael
    Nikolsky, Eugenia
    [J]. EUROINTERVENTION, 2009, 5 (05) : 604 - 609